An additional approach with the HIS-mouse model is the ability to genetically manipulate the HSC prior to “humanization,” and thus track a tumor-specific T cell receptor (112) or test the role of distinct genes in a response (e.g. knock-out IFNγ). The gene discussed is IFNG; the disease is neoplasm.